Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Irritable Bowel Syndrome, May 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 91 articles:
HTML format


 

Single Articles

  1. TSUSHIMA H, Yanli Z, Muratsubaki T, Kanazawa M, et al
    Oxytocin Antagonist Induced Visceral Pain and Corticotropin-Releasing Hormone Neuronal Activation in the Central Nucleus of the Amygdala during Colorectal Distention in Mice.
    Neurosci Res. 2021 Apr 28. pii: S0168-0102(21)00095.
    PubMed    
    Abstract available

  2. GENG H, Weng SJ, Zhao TT, Chen L, et al
    [Mind-regulating and spleen-strengthening needling technique improves abdominal hypersensitivity and emotion by enhancing functional connectivity between hippocampus and brain regions in diarrhea-predominant irritable bowel syndrome patients].
    Zhen Ci Yan Jiu. 2021;46:318-25.
    PubMed    
    Abstract available

  3. CHEN Y, Zhao Y, Wang L, Yao JP, et al
    [Involvement of Pirt /TRPV1 signaling in acupuncture-induced reduction of visceral hypersensitivity in diarrhea-predominant irritable bowel syndrome rats].
    Zhen Ci Yan Jiu. 2021;46:278-83.
    PubMed    
    Abstract available


  4. PMA-zeolite can modulate inflammation associated markers in irritable bowel disease - an explorative randomized, double blinded, controlled pilot trial.
    Neuro Endocrinol Lett. 2021;42.
    PubMed    
    Abstract available

  5. ALTOMARE A, Del Chierico F, Rocchi G, Emerenziani S, et al
    Association between Dietary Habits and Fecal Microbiota Composition in Irritable Bowel Syndrome Patients: A Pilot Study.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  6. OOI SL, Pak SC, Micalos PS, Schupfer E, et al
    The Health-Promoting Properties and Clinical Applications of Rice Bran Arabinoxylan Modified with Shiitake Mushroom Enzyme-A Narrative Review.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  7. CLANCY AK, Lee C, Hamblin H, Gunaratne AW, et al
    Dietary Intakes of Recipients of Faecal Microbiota Transplantation: An Observational Pilot Study.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  8. YEH TC, Bai YM, Tsai SJ, Chen TJ, et al
    Risks of Major Mental Disorders and Irritable Bowel Syndrome among the Offspring of Parents with Irritable Bowel Syndrome: A Nationwide Study.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  9. KWOJI ID, Aiyegoro OA, Okpeku M, Adeleke MA, et al
    Multi-Strain Probiotics: Synergy among Isolates Enhances Biological Activities.
    Biology (Basel). 2021;10.
    PubMed    
    Abstract available

  10. SALVADOR F, Lobo B, Goterris L, Alonso-Cotoner C, et al
    Blastocystis sp. Carriage and Irritable Bowel Syndrome: Is the Association Already Established?
    Biology (Basel). 2021;10.
    PubMed    
    Abstract available

  11. PITSCH J, Sandner G, Huemer J, Huemer M, et al
    FODMAP Fingerprinting of Bakery Products and Sourdoughs: Quantitative Assessment and Content Reduction through Fermentation.
    Foods. 2021;10.
    PubMed    
    Abstract available

  12. NA W, Lee Y, Kim H, Kim YS, et al
    High-Fat Foods and FODMAPs Containing Gluten Foods Primarily Contribute to Symptoms of Irritable Bowel Syndrome in Korean Adults.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  13. MARRAS L, Caputo M, Bisicchia S, Soato M, et al
    The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia.
    Microorganisms. 2021;9.
    PubMed    
    Abstract available

  14. O'BRIEN L, Wall CL, Wilkinson TJ, Gearry RB, et al
    What Are the Pearls and Pitfalls of the Dietary Management for Chronic Diarrhoea?
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  15. CHIU HF, Venkatakrishnan K, Golovinskaia O, Wang CK, et al
    Gastroprotective Effects of Polyphenols against Various Gastro-Intestinal Disorders: A Mini-Review with Special Focus on Clinical Evidence.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  16. CHEN HH, Hung CH, Kao AW, Hsieh HF, et al
    Exploring Quality of Life, Stress, and Risk Factors Associated with Irritable Bowel Syndrome for Female University Students in Taiwan.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  17. SCACIOTA ACL, Matos D, Rosa MMB, Colovati MES, et al
    INTERVENTIONS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME: A REVIEW OF COCHRANE SYSTEMATIC REVIEWS.
    Arq Gastroenterol. 2021;58:120-126.
    PubMed    
    Abstract available

  18. GUO J, Sun JH, Chen L, Geng H, et al
    [Correlation between curative effect and 5-HTTLPR polymorphism in treatment of diarrhea-predominant irritable bowel syndrome with acupuncture for regulating shen and strengthening spleen].
    Zhongguo Zhen Jiu. 2021;41:365-70.
    PubMed    
    Abstract available

  19. CURRO D
    Current evidence on the therapeutic use of fibre in irritable bowel syndrome.
    Expert Rev Gastroenterol Hepatol. 2021.
    PubMed    
    Abstract available

  20. PATEL S, Doerfler B, Boutros K, Ng S, et al
    Review of Treatment Options for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation.
    Int J Gen Med. 2021;14:1457-1468.
    PubMed    
    Abstract available

  21. DANNE C, Rolhion N, Sokol H
    Recipient factors in faecal microbiota transplantation: one stool does not fit all.
    Nat Rev Gastroenterol Hepatol. 2021 Apr 27. pii: 10.1038/s41575-021-00441.
    PubMed    
    Abstract available

  22. HE Y, Tan Y, Zhu J, Wu X, et al
    Effect of sodium butyrate regulating IRAK1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism.
    Bioengineered. 2021;12:1436-1444.
    PubMed    
    Abstract available

  23. LADEN BF, Bresee C, De Hoedt A, Dallas KB, et al
    Comorbidities in a Nationwide, Heterogenous Population of Veterans with Interstitial Cystitis/Bladder Pain Syndrome.
    Urology. 2021 Apr 23. pii: S0090-4295(21)00343.
    PubMed    
    Abstract available

  24. GARG P
    Inflammation in Irritable Bowel Syndrome (IBS): Role of Psyllium Fiber Supplementation in Decreasing Inflammation and Physiological Management of IBS.
    Turk J Gastroenterol. 2021;32:108-110.
    PubMed    


  25. ORLANDO MS, Moulder JK, Carrillo JF, Carey ET, et al
    Chronic pelvic pain educational experience among Minimally Invasive Gynecologic Surgery fellows and recent graduates: a needs assessment.
    J Minim Invasive Gynecol. 2021 May 4. pii: S1553-4650(21)00199.
    PubMed    
    Abstract available

  26. GIANG J, Lan X, Crichton M, Marx W, et al
    Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases or irritable bowel syndrome: A systematic literature review and meta-analysis.
    Nutr Diet. 2021 May 7. doi: 10.1111/1747-0080.12672.
    PubMed    
    Abstract available

  27. KILLIAN LA, Muir JG, Barrett JS, Burd NA, et al
    High Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Consumption Among Endurance Athletes and Relationship to Gastrointestinal Symptoms.
    Front Nutr. 2021;8:637160.
    PubMed    
    Abstract available

  28. NOZU T, Miyagishi S, Ishioh M, Takakusaki K, et al
    Phlorizin attenuates visceral hypersensitivity and colonic hyperpermeability in a rat model of irritable bowel syndrome.
    Biomed Pharmacother. 2021;139:111649.
    PubMed    
    Abstract available

  29. GOODOORY VC, Houghton LA, Yiannakou Y, Black CJ, et al
    Natural History and Disease Impact of Rome IV versus Rome III Irritable Bowel Syndrome: A Longitudinal Follow-up Study.
    Clin Gastroenterol Hepatol. 2021 May 3. pii: S1542-3565(21)00501.
    PubMed    
    Abstract available

  30. WIKLUND CA, Rania M, Kuja-Halkola R, Thornton LM, et al
    Evaluating disorders of gut-brain interaction in eating disorders.
    Int J Eat Disord. 2021 May 6. doi: 10.1002/eat.23527.
    PubMed    
    Abstract available

  31. CASH BD, Lacy BE, Watton C, Schoenfeld PS, et al
    Post-marketing reports of pancreatitis in eluxadoline-treated patients pre and post US label change.
    Therap Adv Gastroenterol. 2021;14:17562848211001725.
    PubMed    
    Abstract available

  32. GHOSHAL UC
    Antibiotic treatment for small intestinal bacterial overgrowth: Is a cocktail better than a single?
    United European Gastroenterol J. 2021 May 5. doi: 10.1002/ueg2.12075.
    PubMed    


  33. DUMITRASCU DL, Baban A, Bancila I, Barboi O, et al
    Romanian Guidelines for Nonpharmacological Therapy of IBS.
    J Gastrointestin Liver Dis. 2021 May 3. doi: 10.15403/jgld-3581.
    PubMed    
    Abstract available

  34. YUAN T, Orock A, Greenwood-Van Meerveld B
    Amygdala microglia modify neuronal plasticity via complement C1q/C3-CR3 signaling and contribute to visceral pain in a rat model.
    Am J Physiol Gastrointest Liver Physiol. 2021.
    PubMed    
    Abstract available

  35. BRIZUELA M, Castro J, Harrington A, Brierley SM, et al
    Pruritogenic mechanisms and gut sensation: Putting the 'irritant' into Irritable Bowel Syndrome.
    Am J Physiol Gastrointest Liver Physiol. 2021.
    PubMed    
    Abstract available

  36. ORTEGA MV, Kim Y, Mitchell C, James K, et al
    Urinary symptoms in women with faecal incontinence.
    Colorectal Dis. 2021 May 4. doi: 10.1111/codi.15703.
    PubMed    
    Abstract available

  37. ALTOMARE A, Di Rosa C, Imperia E, Emerenziani S, et al
    Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  38. O'BRIEN R, Buckley MM, O'Malley D
    Divergent effects of exendin-4 and interleukin-6 on rat colonic secretory and contractile activity are associated with changes in regional vagal afferent signaling.
    Neurogastroenterol Motil. 2021 May 4:e14160. doi: 10.1111/nmo.14160.
    PubMed    
    Abstract available

  39. SNIJKERS JTW, van den Oever W, Weerts ZZRM, Vork L, et al
    Examining the optimal cutoff values of HADS, PHQ-9 and GAD-7 as screening instruments for depression and anxiety in irritable bowel syndrome.
    Neurogastroenterol Motil. 2021 May 3:e14161. doi: 10.1111/nmo.14161.
    PubMed    
    Abstract available

  40. LOBO DE SA FD, Heimesaat MM, Bereswill S, Nattramilarasu PK, et al
    Resveratrol Prevents Campylobacter jejuni-Induced Leaky gut by Restoring Occludin and Claudin-5 in the Paracellular Leak Pathway.
    Front Pharmacol. 2021;12:640572.
    PubMed    
    Abstract available

  41. MOSSALLAM SF, El-Mansoury SAT, Tolba MM, Kohla AA, et al
    In vitro susceptibility of human Blastocystis subtypes to simeprevir.
    Saudi J Biol Sci. 2021;28:2491-2501.
    PubMed    
    Abstract available

  42. SHERWIN LB, Deroche CB, Yevu-Johnson J, Matteson-Kome M, et al
    Usability Evaluation of a Smartphone Medication Reminder Application in Patients Treated With Short-term Antibiotic.
    Comput Inform Nurs. 2021 Apr 29. pii: 00024665-900000000-99289.
    PubMed    
    Abstract available

  43. OLIVIERO G, Ruggiero L, D'Antonio E, Gagliardi M, et al
    Impact of COVID-19 lockdown on symptoms in patients with functional gastrointestinal disorders: Relationship with anxiety and perceived stress.
    Neurogastroenterol Motil. 2021;33:e14092.
    PubMed    
    Abstract available

  44. GEMIGNANI F
    Irritable bowel syndrome, restless legs syndrome, small fiber neuropathy, and fibromyalgia.
    Sleep Med. 2021;83:4.
    PubMed    


  45. BRAGA EMIDIO N, Tran HNT, Andersson A, Dawson PE, et al
    Improving the Gastrointestinal Stability of Linaclotide.
    J Med Chem. 2021 May 12. doi: 10.1021/acs.jmedchem.1c00380.
    PubMed    
    Abstract available

  46. SCARPELLINI E, Basilico M, Rinninella E, Carbone F, et al
    Probiotics and gut health.
    Minerva Gastroenterol (Torino). 2021 May 12. pii: S2724-5985.21.02910.
    PubMed    
    Abstract available

  47. LI X, Liu Q, Yu J, Zhang R, et al
    Costunolide ameliorates intestinal dysfunction and depressive behaviour in mice with stress-induced irritable bowel syndrome via colonic mast cell activation and central 5-hydroxytryptamine metabolism.
    Food Funct. 2021;12:4142-4151.
    PubMed    
    Abstract available

  48. ALI H, Pamarthy R, Sarfraz S
    Role of Prucalopride in Treating Functional Constipation and Gastroparesis: A Systemic Review.
    Cureus. 2021;13:e14306.
    PubMed    
    Abstract available

  49. MOHTA S, Rajput MS, Ahuja V, Makharia GK, et al
    Emergence of Celiac disease and Gluten-related disorders in Asia.
    J Neurogastroenterol Motil. 2021 May 6. pii: jnm20140. doi: 10.5056/jnm20140.
    PubMed    
    Abstract available

  50. DEIN EJ, Wigley FM, McMahan ZH
    Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis.
    BMC Gastroenterol. 2021;21:174.
    PubMed    
    Abstract available

  51. PALOMBO G, Merone M, Altomare A, Gori M, et al
    The impact of the intestinal microbiota and the mucosal permeability on three different antibiotic drugs.
    Eur J Pharm Sci. 2021 May 18:105869. doi: 10.1016/j.ejps.2021.105869.
    PubMed    
    Abstract available

  52. SHIKH EV, Makhova AA, Astapovskiy AA, Perkov AV, et al
    [Prospects of probiotic strains of bifidobacteria and enterococcus in treatment and prevention of diseases in gastroenterology].
    Vopr Pitan. 2021;90:15-25.
    PubMed    
    Abstract available

  53. DIXIT K, Chaudhari D, Dhotre D, Shouche Y, et al
    Restoration of dysbiotic human gut microbiome for homeostasis.
    Life Sci. 2021;278:119622.
    PubMed    
    Abstract available

  54. MORI R, Oyama Y, Morita M, Nakamura S, et al
    [A CASE OF REPEATED DRUG-INDUCED LUNG DISEASES DUE TO MULTIPLE HERBAL MEDICINES CONTAINING COMMON INGREDIENTS].
    Arerugi. 2021;70:204-209.
    PubMed    
    Abstract available

  55. UMRANI S, Jamshed W, Rizwan A
    Association Between Psychological Disorders and Irritable Bowel Syndrome.
    Cureus. 2021;13:e14513.
    PubMed    
    Abstract available

  56. VAN ORTEN-LUITEN AB, de Roos NM, Majait S, Witteman BJM, et al
    Effects of Cannabidiol Chewing Gum on Perceived Pain and Well-Being of Irritable Bowel Syndrome Patients: A Placebo-Controlled Crossover Exploratory Intervention Study with Symptom-Driven Dosing.
    Cannabis Cannabinoid Res. 2021 Feb 11. doi: 10.1089/can.2020.0087.
    PubMed    
    Abstract available

  57. KROGSGAARD LR, Bytzer P
    [Cognitive behavioural therapy for refractory irritable bowel syndrome].
    Ugeskr Laeger. 2021;183.
    PubMed    
    Abstract available

  58. LACY BE, Brenner DM, Chey WD
    Reevaluation of the Cardiovascular Safety Profile of Tegaserod: A Review of the Clinical Data.
    Clin Gastroenterol Hepatol. 2021 May 25. pii: S1542-3565(21)00578.
    PubMed    
    Abstract available

  59. HOU JJ, Wang X, Li Y, Su S, et al
    The relationship between gut microbiota and proteolytic activity in irritable bowel syndrome.
    Microb Pathog. 2021 May 25:104995. doi: 10.1016/j.micpath.2021.104995.
    PubMed    
    Abstract available

  60. PIETRZAK A
    Antispasmodics in irritable bowel syndrome - a hoary old chestnut?
    Saudi J Gastroenterol. 2021 May 21. pii: 316603. doi: 10.4103.
    PubMed    


  61. SHRIVASTAVA A, Mittal A
    A Mini Review on Characteristics and Analytical Methods of Otilonium Bromide.
    Crit Rev Anal Chem. 2021 May 26:1-9. doi: 10.1080/10408347.2021.1913983.
    PubMed    
    Abstract available

  62. SARICA AS, Bor S, Orman MN, Barajas-Martinez H, et al
    Frequency of Irritable Bowel Syndrome in Patients with Brugada Syndrome and Drug-Induced Type 1 Brugada Pattern.
    Am J Cardiol. 2021 May 22. pii: S0002-9149(21)00363.
    PubMed    
    Abstract available

  63. LI J, Wang C, Li ZM, Fu B, et al
    Abnormalities of intrinsic brain activity in irritable bowel syndrome (IBS): A protocol for systematic review and meta analysis of resting-state functional imaging.
    Medicine (Baltimore). 2021;100:e25883.
    PubMed    
    Abstract available

  64. CALLAHAN SM, Dolislager CG, Johnson JG
    The host cellular immune response to infection by Campylobacter spp. and its role in disease.
    Infect Immun. 2021 May 24. pii: IAI.00116-21. doi: 10.1128/IAI.00116.
    PubMed    
    Abstract available

  65. NOZU T, Miyagishi S, Nozu R, Ishioh M, et al
    EMA401, an angiotensin II type 2 receptor antagonist blocks visceral hypersensitivity and colonic hyperpermeability in rat model of irritable bowel syndrome.
    J Pharmacol Sci. 2021;146:121-124.
    PubMed    
    Abstract available

  66. MARI A, Sbeit W, Pellicano R, Khoury T, et al
    The interplay between pancreatic enzymes insufficiency and irritable bowel syndrome.
    Minerva Gastroenterol (Torino). 2021;67:173-174.
    PubMed    


  67. ROGERS AE, Hu YJ, Yue Y, Wissel EF, et al
    Shiftwork, functional bowel symptoms, and the microbiome.
    PeerJ. 2021;9:e11406.
    PubMed    
    Abstract available

  68. EL-SALHY M, Casen C, Valeur J, Hausken T, et al
    Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
    World J Gastroenterol. 2021;27:2219-2237.
    PubMed    
    Abstract available

  69. PEREZ DE ARCE E, Quera R, Beltran CJ, Madrid AM, et al
    Irritable Bowel Syndrome in Inflammatory Bowel Disease. Synergy in alterations of the gut-brain axis?
    Gastroenterol Hepatol. 2021 May 20. pii: S0210-5705(21)00143.
    PubMed    
    Abstract available

  70. PROSPERO L, Riezzo G, Linsalata M, Orlando A, et al
    Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity.
    BMC Gastroenterol. 2021;21:235.
    PubMed    
    Abstract available

  71. LENHART A, Dong T, Joshi S, Jaffe N, et al
    Effect of Exclusion Diets on Symptom Severity and the Gut Microbiota in Patients with Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2021 May 19. pii: S1542-3565(21)00565.
    PubMed    
    Abstract available

  72. LI DH, Li ZP, Yan-Zhang, Zhou GZ, et al
    Fecal Fusobacterium nucleatum harbored virulence gene fadA are associated with ulcerative colitis and clinical outcomes.
    Microb Pathog. 2021 May 19:104964. doi: 10.1016/j.micpath.2021.104964.
    PubMed    
    Abstract available

  73. TALLEY NJ, Powell N, Walker MM, Jones MP, et al
    Role of smoking in functional dyspepsia and irritable bowel syndrome: three random population-based studies.
    Aliment Pharmacol Ther. 2021 May 13. doi: 10.1111/apt.16372.
    PubMed    
    Abstract available

  74. SIMONS M, Taft TH
    Editorial: co-morbid gastrointestinal conditions are an important consideration in IBS management.
    Aliment Pharmacol Ther. 2021;53:1151-1152.
    PubMed    


  75. BLACK CJ, Ford AC
    Editorial: co-morbid gastrointestinal conditions are an important consideration in IBS management-authors' reply.
    Aliment Pharmacol Ther. 2021;53:1153-1154.
    PubMed    



  76. Irritable Bowel Syndrome, Altitude Illness, Transfusions, Group B Streptococcus, Acute Pain.
    Am Fam Physician. 2021;103:586.
    PubMed    


  77. MIDENFJORD I, Borg A, Tornblom H, Simren M, et al
    Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2021;116:769-779.
    PubMed    
    Abstract available

  78. SHAH ED, Chang L, Salwen-Deremer JK, Gibson PR, et al
    Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis.
    Am J Gastroenterol. 2021;116:748-757.
    PubMed    
    Abstract available

  79. SCHMULSON M
    Probiotics: To Use or Not to Use? That Is the Question.
    Am J Gastroenterol. 2021 May 10. pii: 00000434-900000000-98783.
    PubMed    
    Abstract available

  80. YU V, Ballou S, Hassan R, Singh P, et al
    Abdominal Pain and Depression, Not Bowel Habits, Predict Health Care Utilization in Patients With Functional Bowel Disorders.
    Am J Gastroenterol. 2021 May 18. pii: 00000434-900000000-98775.
    PubMed    
    Abstract available

  81. BRENNER DM, Lacy BE
    Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98778.
    PubMed    
    Abstract available

  82. SHAH ED, Lacy BE, Chey WD, Chang L, et al
    Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials.
    Am J Gastroenterol. 2021 May 25. pii: 00000434-900000000-98765.
    PubMed    
    Abstract available

  83. HESSER H, Hedman-Lagerlof E, Lindfors P, Andersson E, et al
    Behavioral avoidance moderates the effect of exposure therapy for irritable bowel syndrome: A secondary analysis of results from a randomized component trial.
    Behav Res Ther. 2021;141:103862.
    PubMed    
    Abstract available

  84. NOURI-MAJD S, Salari-Moghaddam A, Hassanzadeh Keshteli A, Esmaillzadeh A, et al
    The association between adherence to the MIND diet and irritable bowel syndrome.
    Dig Dis. 2021 May 5. pii: 000517015. doi: 10.1159/000517015.
    PubMed    


  85. BERUMEN A, Edwinson AL, Grover M
    Post-infection Irritable Bowel Syndrome.
    Gastroenterol Clin North Am. 2021;50:445-461.
    PubMed    
    Abstract available

  86. VASANT DH, Paine PA, Black CJ, Houghton LA, et al
    British Society of Gastroenterology guidelines on the management of irritable bowel syndrome.
    Gut. 2021 Apr 26. pii: gutjnl-2021-324598. doi: 10.1136/gutjnl-2021-324598.
    PubMed    
    Abstract available

  87. SAHA S, Sehgal K, Singh S, Grover M, et al
    Postinfection Irritable Bowel Syndrome Following Clostridioides difficile Infection: A Systematic-review and Meta-analysis.
    J Clin Gastroenterol. 2021 May 28. pii: 00004836-900000000-97410.
    PubMed    
    Abstract available

  88. CHUMPITAZI BP, Palermo TM, Hollier JM, Self MM, et al
    Multisite Pain is Highly Prevalent in Children with Functional Abdominal Pain Disorders and is Associated with Increased Morbidity.
    J Pediatr. 2021 Apr 30. pii: S0022-3476(21)00411.
    PubMed    
    Abstract available

  89. SHORT P, Burklow CS, Nylund CM, Susi A, et al
    Impact of Parental Illness and Injury on Pediatric Disorders of Gut-Brain Interaction.
    J Pediatr. 2021 May 12. pii: S0022-3476(21)00440.
    PubMed    
    Abstract available

  90. BEINVOGL BC, Manini ML, Camilleri M, Donato LJ, et al
    Markers of Bile Acid Metabolism in Pediatric Diarrhea Predominant Irritable Bowel Syndrome and Healthy Controls.
    J Pediatr Gastroenterol Nutr. 2021;72:859-865.
    PubMed    
    Abstract available

  91. MADSEN AMA, Halkjaer SI, Christensen AH, Gunther S, et al
    The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study.
    Scand J Gastroenterol. 2021 May 17:1-9. doi: 10.1080/00365521.2021.1915375.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;